Caredx Inc’s filing revealed that its Director HAGSTROM WILLIAM A unloaded Company’s shares for reported $0.39 million on Jun 11 ’25. In the deal valued at $19.90 per share,19,391 shares were sold. As a result of this transaction, HAGSTROM WILLIAM A now holds 53,979 shares worth roughly $1.03 million.
Then, WILLIAM HAGSTROM bought 19,391 shares, generating $385,918 in total proceeds.
Before that, HAGSTROM WILLIAM A sold 30,000 shares. Caredx Inc shares valued at $523,413 were divested by the Director at a price of $17.45 per share. As a result of the transaction, HAGSTROM WILLIAM A now holds 53,979 shares, worth roughly $1.03 million.
Wells Fargo upgraded its Caredx Inc [CDNA] rating to an Equal weight from a an Underweight in a research note published on January 15, 2025; the price target was decreased to $24 from $28. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late August with a ‘”an Underweight”‘ rating. BTIG Research also remained covering CDNA and has increased its forecast on August 19, 2024 with a “Buy” recommendation from previously “Neutral” rating. Raymond James revised its rating on May 13, 2024. It rated CDNA as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of CDNA
On Monday, Caredx Inc [NASDAQ:CDNA] saw its stock jump 2.58% to $19.07. Over the last five days, the stock has lost -3.30%. Caredx Inc shares have fallen nearly -10.93% since the year began. Nevertheless, the stocks have risen 24.72% over the past one year. While a 52-week high of $34.84 was reached on 01/14/25, a 52-week low of $13.18 was recorded on 05/06/25.
Levels Of Support And Resistance For CDNA Stock
The 24-hour chart illustrates a support level at 18.69, which if violated will result in even more drops to 18.31. On the upside, there is a resistance level at 19.34. A further resistance level may holdings at 19.61.
